Venous thromboembolic events (VTE) in patients treated with cisplatin as compared to carboplatin-containing regimens

被引：0
|
作者：
Dixit, N.
Ijaz, A.
Martin, L. A.
Lee, M. H.
机构：
[1] Caritas St Elizabeth Med Ctr, Boston, MA USA
[2] Tufts Univ, Sch Med, Dept Med, Caritas St Elizabeth Med Ctr, Boston, MA 02111 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e19679
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19679
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Incidence of venous thromboembolic events (VTE) in multiple myeloma patients receiving lenalidomide (LEN) with and without dexamethasone (DEX).
    Brandenburg, Nancy A.
    Knight, Tyler
    Anastassopoulos, Kathryn P.
    Minton, Neil
    Knight, Robert D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [22] Perioperative venous thromboembolic events (VTE): can we lower the risk ever further?
    McCready, Robert Alan
    JOURNAL OF SURGICAL RESEARCH, 2013, 185 (02) : 528 - 529
  • [23] The high incidence of vascular thromboembolic events (VTE) in advanced urothelial cancer (UC) patients (pts) treated with carboplatin (Cb): Analysis of treatment with gemcitabine (G)/cb (GCb), gcb/bevacizumab (GCbBev), or gemcitabine/cisplatin (GCis)
    Tully, Christopher Michael
    Apolo, Andrea Borghese
    Zabor, Emily C.
    Regazzi, Ashley Marie
    Ostrovnaya, Irina
    Rosenberg, Jonathan E.
    Bajorin, Dean F.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [24] 2008 Standards, Options: Recommendations for venous thromboembolic events (VTE) treatment and central venous catheter thrombosis (CVCT) management in cancer patients
    JOURNAL DES MALADIES VASCULAIRES, 2008, 33 (03) : 140 - 154
  • [25] Down-regulation of immune checkpoints by doxorubicin and carboplatin-containing neoadjuvant regimens in a murine breast cancer model
    Sadighi, Sanambar
    Sharifian, Ramezanali
    Kazemimanesh, Monireh
    Muhammadnejad, Ahad
    Shohosseini, Zahra
    Amanpour, Saeid
    Muhammadnejad, Samad
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 24 (04) : 537 - 544
  • [26] Venous thromboembolic events in hospitalised medical patients
    Piazza, Gregory
    Fanikos, John
    Zayaruzny, Maksim
    Goldhaber, Samuel Z.
    THROMBOSIS AND HAEMOSTASIS, 2009, 102 (03) : 505 - 510
  • [27] Venous thromboembolic events in hospitalized trauma patients
    Azu, Michelle C.
    Mccormack, Jane E.
    Huang, Emily C.
    Lee, Thomas K.
    Shapiro, Marc J.
    AMERICAN SURGEON, 2007, 73 (12) : 1228 - 1231
  • [28] Incidence of venous thromboembolic (VTE) in chronic lymphocytic leukemia (CLL) patients (pts) treated with immunomodulating agents (IMiDs).
    Depaolo, D.
    Miller, K.
    Musial, L.
    Marshall, P.
    Coignet, J.
    Padmanabhan, S.
    Chanan-Khan, A. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 499S - 499S
  • [29] Prevalence of renal insufficiency in hospitalised patients with venous thromboembolic events: A retrospective analysis based on 6,725 VTE patients
    Boettger, Bjoern
    Wehling, Martin
    Bauersachs, Rupert M.
    Amann, Steffen
    Schuchert, Andreas
    Reinhold, Christian
    Kuempers, Philipp
    Wilke, Thomas
    THROMBOSIS RESEARCH, 2014, 134 (05) : 1014 - 1019
  • [30] Venous Thromboembolic Events in African American Lupus Patients in Association With Antiphospholipid Antibodies Compared to White Patients
    Gkrouzman, Elena
    Peng, Mary
    Davis-Porada, Julia
    Kirou, Kyriakos A.
    ARTHRITIS CARE & RESEARCH, 2022, 74 (04) : 656 - 664
12345